---
figid: PMC9487558__ERR-0085-2016.04
pmcid: PMC9487558
image_filename: ERR-0085-2016.04.jpg
figure_link: /pmc/articles/PMC9487558/figure/F4/
number: FIGUREÂ 4
figure_title: ''
caption: 'Future perspectives on the use of combination therapy to treat pulmonary
  arterial hypertension. The choice of combination therapy regimen will be influenced
  by the risk status at diagnosis and the response to initial medical therapy. Inadequate
  clinical response is defined as a patient who does not achieve or maintain a low-risk
  profile [, ]. WHO FC: World Health Organization functional class; NO: nitric oxide;
  ET: endothelin; PGI2: prostacyclin; inh.: inhaled. #: for eligible patients.'
article_title: 'Beyond a single pathway: combination therapy in pulmonary arterial
  hypertension.'
citation: Olivier Sitbon, et al. Eur Respir Rev. 2016 Dec;25(142):408-417.
year: '2016'

doi: 10.1183/16000617.0085-2016
journal_title: European Respiratory Review
journal_nlm_ta: Eur Respir Rev
publisher_name: European Respiratory Society

keywords:
---
